Hepatitis-Bvaccine IP Vaccine

Trade Name: Revac -BMCF
Available Strength : 0.5 ML
Available Combination : Revac-B mcf is a sterile suspension containing purified, non-infectious major surface antigen of the Hepatitis-B virus and is manufactured using recombinant DNA technology.
Packing : 1X0.5ml
Pack Insert/Leaflet : YES
Therapeutic use : Revac-B Mcf Vaccine is a vaccine that prepares your child's immune system to fight against the hepatitis B virus. This virus causes a serious liver disease called hepatitis. The vaccine does not contain any live viruses and cannot cause hepatitis B disease in children.
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.